RCT in 120 HSV-seropositive participants with early symptomatic Alzheimer disease: valacyclovir 4 g/d vs placebo did not help and led to greater cognitive worsening at 78 weeks (ADAS-Cog difference 3.93 points); no differences in function, amyloid or tau PET.
RCTn = 120
Devanand et al. Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial